pharma news today glp-1 obesity drug A new weight-loss pill- Foundayo, is making global headlines, with many claiming it could challenge injectable drugs like Wegovy, Ozempic and Mounjaro. But is that really true?, In this video, we Most people know GLP-1 medications
Description
10.1097/CLD.0000000000000202 127 ShabilM.KhatibM
On March 18 th , Oprah kicked off a national conversation on obesity and GLP-1s
Notice an error
These thermoregulatory changes are typically temporary and may improve as weight stabilizes and the body adapts to its new composition
Although other trials, for example the SUSTAIN 6 trial evaluating semaglutide for potential cardiovascular benefits in patients with type 2 diabetes, did not find a sex difference in the rate of reported GI events (51% more than placebo in men, 47% more than placebo in women) or in the rate of treatment discontinuation due to adverse events (76% more than placebo in men, 127% more than placebo in women)
